Clinical Trial Update: Study of FYU-981 in Hyperuricemia With or Without Gout [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FYU-981 for hyperuricemia with or without gout has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• FYU-981

Snippet

Sponsor: Fuji Yakuhin Co., Ltd. | Conditions: Hyperuricemia | Phase 2 | Status: COMPLETED